Future trends in the development of safer nonsteroidal anti-inflammatory drugs

This publication has 47 references indexed in Scilit:

• Multiple Female Reproductive Failures in Cyclooxygenase 2–Deficient Mice
  Published by Elsevier ,1997
• Effect of the Enantiomers of Flurbiprofen, Ibuprofen, and Ketoprofen on Intestinal Permeability
  Journal of Pharmaceutical Sciences, 1996
• Stereoselective Inhibition of Inducible Cyclooxygenase by Chiral Nonsteroidal Antiinflammatory Drugs
  The Journal of Clinical Pharmacology, 1996
• Safety of Meloxicam: A Global Analysis of Clinical Trials
  Rheumatology, 1996
• A 4-Week, Double-Blind, Parallel-Group Study to Compare the Gastrointestinal Effects of Meloxicam 7.5 mg, Meloxicam 15 mg, Piroxicam 20 mg and Placebo by Means of Faecal Blood Loss, Endoscopy and Symptom Evaluation in Healthy Volunteers
  Rheumatology, 1996
• A randomized, double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production
  Gastrointestinal Endoscopy, 1995
• Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II
  Nature, 1995
• A double‐blind gastroscopic evaluation of the effects of etodolac and naproxen on the gastrointestinal mucosa of rheumatic patients
  Journal of Internal Medicine, 1991
• Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues
  The Journal of Pathology, 1990
• Southwestern Internal Medicine Conference: Prostaglandins and Gastric Ulcers: From Seminal Vesicle to Misoprostol (Cytotec®)
  The Lancet Healthy Longevity, 1990